CAMBRIDGE, Mass., October 23, 2025--(BUSINESS WIRE)--Sail Biomedicines, a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Martin Mackay, Ph.D., has ...
CAMBRIDGE, Mass., April 07, 2025--(BUSINESS WIRE)--Sail Biomedicines, Inc. ("Sail"), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Laura ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback